Natural Product Drug Discovery: Highly Anticipated Natural Molecules , a new volume in the Drug Discovery Opinion series, provides a comprehensive examination of the role of natural products in innovative drug development. The book addresses the significant challenges that highly active natural molecules face in the drug development process, including issues related to bioavailability and potency. Sections present analyses of various classes of natural products, including polysaccharides, volatile oils, and diterpenoids, exploring their chemical properties, biological activities, and potential clinical applications. Each chapter, written by leading experts, offers insights into structural modification techniques, naturally sourced inhibitors, and the application of green biomanufacturing strategies. It will serve as an essential resource for researchers, pharmacologists, and industry professionals involved in natural product drug discovery. Readers will find the necessary information to navigate the complexities of the field, emphasizing the integration of traditional knowledge with modern scientific approaches. Through a thorough understanding of these natural compounds, this book aims to contribute to the advancement of therapeutic innovations in pharmacotherapy. Provides a comprehensive analysis of natural products' chemical properties and biological activities for informed drug development - Explores challenges and solutions in the commercialization of highly active natural molecules - Features expert contributions that offer insights into structural modification and green biomanufacturing strategies - Includes case studies that illustrate successful applications of natural products in therapeutic contexts - Serves as an essential resource for researchers and professionals in natural product drug discovery and pharmacotherapy Provides a comprehensive analysis of highly active natural products, addressing challenges and solutions in drug development, including expert insights and case studies Natural Product Drug Discovery: Highly Anticipated Natural Molecules provides a comprehensive examination of the role of natural products in innovative drug development. This research level reference addresses the significant challenges that highly active natural molecules face in the drug development process, including issues related to bioavailability and potency. The book presents detailed analyses of various classes of natural products, including polysaccharides, volatile oils, and diterpenoids, exploring their chemical properties, biological activities, and potential clinical applications. Each chapter is authored by leading experts in the field, offering insights into structural modification techniques, naturally sourced inhibitors, and the application of green biomanufacturing strategies to enhance drug development. This volume in the Drug Discovery Opinion series serves as an essential resource for researchers, pharmacologists, and industry professionals involved in natural product drug discovery. It provides the necessary information to navigate the complexities of this field, emphasizing the integration of traditional knowledge with modern scientific approaches. Through a thorough understanding of these natural compounds, this book aims to contribute to the advancement of therapeutic innovations in pharmacotherapy. Professor Ning Li is the associate dean of Chinese Materia Medica of Shenyang Pharmaceutical University, the "Youth talent" of Liao Ning Revitalization Talents Program, the "Talent of Hundred level" of Liaoning Bai Qian Wan Talents Program, the "Leading talent" of both Shenyang High-Level Talent Program and Xinjiang Uygur Autonomous Region. She has focused on the research of chemoprevention of critical diseases, especially the neurodegenerative disease and cancer, through post-transcriptional mechanism on the perspective view of ‘preventive treatment strategy’ of the Traditional Chinese theory. She has hosted seven projects of National Natural Science Foundation of China and published more than 120 SCI papers on famous academic journals, born several prizes like the "First Prize of Provincial Science and technology progress award", and obtained the authorization of 20 invention patents. Professor Yang Liu, currently serves as the Dean of the School of Pharmaceutical Engineering, the Chairman of the Pharmaceutical Engineering Discipline and the Chairman of the Biology and Medicine Discipline at Shenyang Pharmaceutical University, P. R. China. He received his Bachelor and Master Degrees from Hunan University, and Doctoral Degree from Shenyang Pharmaceutical University. Professor Liu has been engaged in innovative research of medicinal chemistry for a long time, leading his group to carry out researches on innovative drugs and modified new drugs for treatment of malignant tumors, diabetes, AD and other major diseases, developing drug preparation technologies suitable for industrial productio